• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中中枢神经系统来源的外泌体α-突触核蛋白可能是帕金森病的生物标志物。

Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.

机构信息

Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Department of Neurology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Neuroscience. 2019 Aug 10;413:308-316. doi: 10.1016/j.neuroscience.2019.05.015. Epub 2019 May 16.

DOI:10.1016/j.neuroscience.2019.05.015
PMID:31102760
Abstract

Parkinson's disease (PD) is a common movement disorder. Alpha-synuclein (α-synuclein) plays a critical role in PD. In this study, we evaluated the level of central nervous system (CNS)-derived exosomal α-synuclein in serum, which may be regarded as a specific peripheral biomarker for PD. We recruited patients with PD in the early stage along with essential tremor (ET), and we recruited age- and gender-matched healthy subjects as healthy controls (HC). We divided patients with PD into the tremor-dominant (TD) group and the non-tremor-dominant (NTD) group. We evaluated the levels of α-synuclein in CNS-derived exosomes in serum samples. As a result, there was a significant difference between four groups (p<0.05). This level was lower in the PD group than in the ET and HC groups (p<0.05). Among the PD group, this level was lower in the NTD group than in the TD group (p<0.05). Furthermore, the performance of serum CNS-derived exosomal α-synuclein was found to moderately aid in PD diagnosis (AUC=0.675, p<0.05) and had a potential to diagnose NTD (AUC=0.761, p<0.05). Therefore, CNS-derived exosomal α-synuclein in the serum may be regarded as a biomarker to identify PD from ET and HC in the early stage. It may also be used to identify different motor types in PD. The pathogenesis of PD in different motor types may be different, which needs further research.

摘要

帕金森病(PD)是一种常见的运动障碍。α-突触核蛋白(α-synuclein)在 PD 中起着关键作用。在这项研究中,我们评估了血清中中枢神经系统(CNS)衍生的细胞外体α-突触核蛋白的水平,它可能被视为 PD 的一种特定的外周生物标志物。我们招募了早期 PD 患者以及特发性震颤(ET)患者,并招募了年龄和性别匹配的健康受试者作为健康对照组(HC)。我们将 PD 患者分为震颤为主(TD)组和非震颤为主(NTD)组。我们评估了血清样本中 CNS 衍生的细胞外体α-突触核蛋白的水平。结果,四个组之间存在显著差异(p<0.05)。PD 组的水平低于 ET 组和 HC 组(p<0.05)。在 PD 组中,NTD 组的水平低于 TD 组(p<0.05)。此外,发现血清 CNS 衍生的细胞外体α-突触核蛋白的表现有助于中度 PD 诊断(AUC=0.675,p<0.05),并具有诊断 NTD 的潜力(AUC=0.761,p<0.05)。因此,血清中的 CNS 衍生的细胞外体α-突触核蛋白可能被视为一种生物标志物,可用于在早期将 PD 与 ET 和 HC 区分开来。它也可用于识别 PD 中的不同运动类型。不同运动类型的 PD 的发病机制可能不同,这需要进一步研究。

相似文献

1
Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.血清中中枢神经系统来源的外泌体α-突触核蛋白可能是帕金森病的生物标志物。
Neuroscience. 2019 Aug 10;413:308-316. doi: 10.1016/j.neuroscience.2019.05.015. Epub 2019 May 16.
2
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.血浆外泌体α-突触核蛋白可能源自中枢神经系统,且在帕金森病中含量增加。
Acta Neuropathol. 2014 Nov;128(5):639-650. doi: 10.1007/s00401-014-1314-y. Epub 2014 Jul 6.
3
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.血浆 L1CAM 外泌体中的长链非编码 RNA POU3F3 和 α-突触核蛋白与β-葡糖脑苷脂酶活性的结合:帕金森病的潜在预测因子。
Neurotherapeutics. 2020 Jul;17(3):1104-1119. doi: 10.1007/s13311-020-00842-5.
4
Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis.用于帕金森病诊断的外泌体生物标志物的鉴定及其最佳分离和检测方法:系统评价和荟萃分析。
Ageing Res Rev. 2022 Dec;82:101764. doi: 10.1016/j.arr.2022.101764. Epub 2022 Oct 20.
5
Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.血浆外泌体中α-突触核蛋白的种类及寡聚化和磷酸化α-突触核蛋白作为帕金森病潜在外周生物标志物的研究。
Neuroscience. 2021 Aug 10;469:79-90. doi: 10.1016/j.neuroscience.2021.06.033. Epub 2021 Jun 27.
6
Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.血清神经元细胞外囊泡可预测帕金森病与非典型帕金森病,并对两者进行区分。
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):720-729. doi: 10.1136/jnnp-2019-322588. Epub 2020 Apr 9.
7
A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.一项关于血浆神经元外泌体中α-突触核蛋白作为帕金森病发生和进展生物标志物的纵向研究。
Eur J Neurol. 2020 Jun;27(6):967-974. doi: 10.1111/ene.14208. Epub 2020 Apr 13.
8
Potential Exosome Biomarkers for Parkinson's Disease Diagnosis: A Systematic Review and Meta-Analysis.用于帕金森病诊断的潜在外泌体生物标志物:系统评价和荟萃分析。
Int J Mol Sci. 2024 May 13;25(10):5307. doi: 10.3390/ijms25105307.
9
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.候选炎症生物标志物与α-突触核蛋白呈独特关系,并与帕金森病患者疾病严重程度的测量指标相关。
J Neuroinflammation. 2017 Aug 18;14(1):164. doi: 10.1186/s12974-017-0935-1.
10
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆患者脑脊液来源外泌体诱导α-突触核蛋白聚集体形成
Brain. 2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8.

引用本文的文献

1
Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood.从血液中检测和分离组织特异性细胞外囊泡
J Extracell Biol. 2025 Jun 22;4(6):e70059. doi: 10.1002/jex2.70059. eCollection 2025 Jun.
2
Neuronally Derived Extracellular Vesicles' Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson's Disease from Essential Tremor.神经元衍生细胞外囊泡的寡聚体和p129-α-突触核蛋白水平用于帕金森病与特发性震颤的鉴别诊断
Int J Mol Sci. 2025 Apr 17;26(8):3819. doi: 10.3390/ijms26083819.
3
[Recent advances on the role of exosomes in neurodegenerative diseases].
[外泌体在神经退行性疾病中的作用的最新进展]
Se Pu. 2025 May;43(5):487-497. doi: 10.3724/SP.J.1123.2024.10035.
4
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.脑源性细胞外囊泡:帕金森病发病机制、诊断和治疗的一条有前景的途径。
Neural Regen Res. 2025 Apr 29. doi: 10.4103/NRR.NRR-D-24-01262.
5
Extracellular vesicles: translational research and applications in neurology.细胞外囊泡:神经学中的转化研究与应用
Nat Rev Neurol. 2025 May;21(5):265-282. doi: 10.1038/s41582-025-01080-z. Epub 2025 Apr 3.
6
The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead.纳米医学中细胞外囊泡的潜力:近期进展与未来挑战综述
Adv Biol (Weinh). 2024 Dec 31:e2400623. doi: 10.1002/adbi.202400623.
7
Microglia-Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin.小胶质细胞衍生的维生素D结合蛋白通过与神经元受体巨膜蛋白结合介导突触损伤并诱发抑郁。
Adv Sci (Weinh). 2025 Feb;12(6):e2410273. doi: 10.1002/advs.202410273. Epub 2024 Dec 23.
8
α-Synuclein in Parkinson's Disease: From Bench to Bedside.帕金森病中的α-突触核蛋白:从实验台到病床边
Med Res Rev. 2025 May;45(3):909-946. doi: 10.1002/med.22091. Epub 2024 Dec 20.
9
Parkinson disease therapy: current strategies and future research priorities.帕金森病治疗:当前策略与未来研究重点。
Nat Rev Neurol. 2024 Dec;20(12):695-707. doi: 10.1038/s41582-024-01034-x. Epub 2024 Nov 4.
10
The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?外泌体生物标志物的潜力:革新帕金森病:它们如何影响发病机制、诊断和治疗策略?
AIMS Neurosci. 2024 Sep 23;11(3):374-397. doi: 10.3934/Neuroscience.2024023. eCollection 2024.